| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 76 |
| 1 | PREDNISOLONE | 63 |
| 2 | PREDNISOLONE ORAL | 63 |
| 3 | PREDNISOLONE ORAL SOLUTION | 63 |
| 4 | METHOTREXATE SODIUM | 60 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 60 |
| 6 | TACROLIMUS OINTMENT 0.1% | 60 |
| 7 | METHOTREXATE | 57 |
| 8 | ADALIMUMAB | 54 |
| 9 | METFORMIN | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPINOSAD | 1 | 0.0213 |
| 1 | PLOZASIRAN | 1 | 0.0096 |
| 2 | CRIZOTINIB | 46 | 0.0036 |
| 3 | DANICOPAN | 1 | 0.0032 |
| 4 | CASPOFUNGIN ACETATE | 5 | 0.0032 |
| 5 | GLYCERIN SUPPOSITORY | 8 | 0.0030 |
| 6 | GLYCERIN SUPPOSITORIES | 8 | 0.0030 |
| 7 | FLUCYTOSINE | 4 | 0.0028 |
| 8 | BARICITINIB | 8 | 0.0026 |
| 9 | SODIUM HYALURONATE | 2 | 0.0024 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 1 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 2 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 3 | Nucleoside Analog Antifungal [EPC] | 4 | 0.0028 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 18 | 0.0014 |
| 5 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 6 | Glinide [EPC] | 8 | 0.0009 |
| 7 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |
| 8 | Echinocandin Antifungal [EPC] | 7 | 0.0009 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 3 | 0.0007 |